Authors: Luciana Scotti, Marcus T. Scotti

Pharmaceuticals for Targeting Coronaviruses

eBook: US $44 Special Offer (PDF + Printed Copy): US $80
Printed Copy: US $58
Library License: US $176
ISBN: 978-981-5051-31-5 (Print)
ISBN: 978-981-5051-30-8 (Online)
Year of Publication: 2022
DOI: 10.2174/97898150513081220101

Introduction

This reference summarizes information about pharmaceuticals that can target infectious strains of coronaviruses to neutralize infections. Chapters focus on SARS-CoV-2, drug discovery methods and natural methods to combat the virus, which is a causative agent of COVID-19.

Specifically, the book presents 5 chapters written by expert scholar on the following topics:

Structure-Based Drug Discovery Approaches Applied to SARS-CoV-2 (the causative agent COVID- 19)

Potential Antiviral Medicinal Plants against Novel SARS-CoV-2

Infections Caused by SARS Coronaviruses: Main Characteristics, Targets and Inhibitors

Natural Sourced Traditional Indian and Chinese Medicines to Combat COVID- 19

Peptidomimetic and Peptide-Derived Agents Against 3CLpro from Coronaviruses

The book contents present both conventional drug design and traditional approaches to discovering relevant drugs in an easy-to-read approach, which is supplemented by bibliographic references. It is intended as a reference for students (pharmacology, pharmacy) and researchers (virology) who are seeking information about antiviral drugs that can be used against coronaviruses.

Audience: Students and researchers in the field of pharmacology and pharmacy; biochemists and virologists.

RELATED BOOKS

.Anthocyanins: Pharmacology and Nutraceutical Importance.
.Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention.
.Drug Addiction Mechanisms in the Brain.
.Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems.